Research status: Primary-source refreshed through Q2 FY2027 results/10-Q and the 15 Sep 2026 X7 / edge-AI ecosystem announcements. Valuation reference: $68.85 close on 21 Sep 2026.
The Q2 evidence improves the conversion story but does not yet make AMBA capital-ready. Revenue was $108.1M, +13.2% YoY, with record edge-AI revenue and balanced sequential growth across Auto and IoT. GAAP gross margin was 57.7% and non-GAAP gross margin 59.3%. GAAP net loss narrowed to $6.7M (-$0.15/share) and non-GAAP net income rose to $8.2M ($0.18/share). Cash + marketable securities were $272.3M. Management guided Q3 revenue to $115–124M with 59–60% non-GAAP gross margin.
The quality caveat remains important: Q2 GAAP R&D included a $9M one-time development-project termination credit, while stock-based compensation was $22.7M, about 21% of quarterly revenue. So the narrowing GAAP loss should not be treated as pure operating leverage.
Strategically, Sep. 15 broadened the story beyond integrated CVflow SoCs. Ambarella launched X7, its first standalone AI accelerator, and expanded developer / deployment partnerships around Google Cloud, Ultralytics and ZEDEDA. That potentially widens the addressable market from embedded SoC designs to attachable Physical-AI acceleration and lowers software/deployment friction. The next proof is commercial: named production customers, unit volumes, attach economics and whether these ecosystem initiatives raise growth without keeping SBC/R&D structurally excessive.
AMBA remains investigate, but it is more interesting as a genuinely independent Robotics/Physical-AI factor than it was in August. The next full review should now focus on Q3 conversion, X7 design wins and automotive/robotics production milestones rather than waiting on an already-completed Q2 earnings gate.